← Leaderboards
Walden Ai
Columbia University Health Sciences
$1,385,561
Attributed
$1,385,561
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $137.3K · FY2006–25$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,385,561 · 4
By mechanism
K01$519,264 · 1
SC3$389,556 · 1
R16$274,666 · 1
R03$202,075 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Timothy Cragin Wang$52,188,834
- Megan Sykes$56,546,810
- Paul E Harris$8,461,662
- Julian Abrams$10,470,386
- Peter D Canoll$11,470,200
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMediatingMouse ModelDesignCellsMalignant NeoplasmsSignal TransductionMolecularGene ExpressionNamesOverexpressionCell SeparationBaseMalignant Breast NeoplasmMammary NeoplasmsGrowthAreaIn VitroEpithelial CellsFluorescenceGenerationsGklf ProteinDown-RegulationFibroblasts
Grant awards (14)
Targeting cell fusion as a novel strategy to tackle JQ1 resistance in triple negative breast cancer$137,333
R16 · FY2025 · GM · contact PI
Targeting cell fusion as a novel strategy to tackle JQ1 resistance in triple negative breast cancer$137,333
R16 · FY2024 · GM · contact PI
KLF4-mediated myeloid plasticity in breast cancer recurrence$97,389
SC3 · FY2023 · GM · contact PI
KLF4-mediated myeloid plasticity in breast cancer recurrence$97,389
SC3 · FY2022 · GM · contact PI
KLF4-mediated myeloid plasticity in breast cancer recurrence$97,389
SC3 · FY2021 · GM · contact PI
KLF4-mediated myeloid plasticity in breast cancer recurrence$97,389
SC3 · FY2020 · GM · contact PI
Function of KLF4-expressing stem cells in mouse cutaneous wound healing$65,075
R03 · FY2013 · AR · contact PI
Function of KLF4-expressing stem cells in mouse cutaneous wound healing$68,500
R03 · FY2012 · AR · contact PI
Function of KLF4-expressing stem cells in mouse cutaneous wound healing$68,500
R03 · FY2011 · AR · contact PI
Structural Studies and Functional Regulation of KLF4$129,546
K01 · FY2009 · DK · contact PI
Structural Studies and Functional Regulation of KLF4$130,626
K01 · FY2008 · DK · contact PI
Structural Studies and Functional Regulation of KLF4$69,708
K01 · FY2007 · DK · contact PI
Structural Studies and Functional Regulation of KLF4$59,838
K01 · FY2007 · DK · contact PI
Structural Studies and Functional Regulation of KLF4$129,546
K01 · FY2006 · DK · contact PI